Supplementary Methods, Tables 1 - 2, Figures 1 - 8 from Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
Mary E. Vail(Monash University), Martin Lackmann(Monash University), Linda Hii(Monash University), Degu Abebe(Monash University), Varghese Palath(Sunesis (United States)), Carmen Llerena(Monash University), David H. Abramson(Memorial Sloan Kettering Cancer Center), Peter W. Janes(Olivia Newton-John Cancer Wellness & Research Centre), Glenn A. Cartwright(Ludwig Cancer Research), Fook-Thean Lee(Ludwig Cancer Research), Andrew M. Scott(Olivia Newton-John Cancer Wellness & Research Centre), Carmel Murone(Ludwig Cancer Research), Mark Baer, Geoffrey Yarranton, April Tan(Monash University), Christopher Bebbington(Curtin University), Slavisa Garic(Monash University)
Cited by 0
Related Papers
Germline mutations in BAP1 predispose to melanocytic tumors
|Nature Genetics|2011|724
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
|The Journal of Immunology|1998|546
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
|Proceedings of the National Academy of Sciences|2004|440
Antibody–Drug Conjugates for Cancer Therapy
|Molecules|2020|377